Metraipolis › archive › dc_dcf0a2f79d41

Tissue Plasminogen Activator as an Approved Strategy for Ischemic Stroke: A Review of tPA's Structure, Mechanism of Action and the Novel Targeting Methods — Europe PMC PMID:41243045

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41243045
DOI
10.1007/s12031-[numero omesso]-3
License (as archived)
solo-consultazione
Archived
2026-11-08T12:24:27.090Z
SHA-256 of the archived text
bc1390a1c9b3be99ffa6633e0cde3e55f2c2760c19088fe2fedb3e4a78ff46b5
Stable URL of this page
https://metraipolis.com/documento/dc_dcf0a2f79d41

How to cite

Tissue Plasminogen Activator as an Approved Strategy for Ischemic Stroke: A Review of tPA's Structure, Mechanism of Action and the Novel Targeting Methods — Europe PMC PMID:41243045 — Europe PMC (en), https://europepmc.org/article/MED/41243045 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dcf0a2f79d41 (Metraipolis archive dc_dcf0a2f79d41, sha256 bc1390a1c9b3be99ffa6633e0cde3e55f2c2760c19088fe2fedb3e4a78ff46b5)
BibTeX
@misc{dcdcf0a2f79d41,
  title = {Tissue Plasminogen Activator as an Approved Strategy for Ischemic Stroke: A Review of tPA's Structure, Mechanism of Action and the Novel Targeting Methods — Europe PMC PMID:41243045},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41243045},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dcf0a2f79d41; sha256 bc1390a1c9b3be99ffa6633e0cde3e55f2c2760c19088fe2fedb3e4a78ff46b5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41243045. Agents can read the archived copy with the MCP tool read_document.